Fetal Familial Cerebral Cavernous Malformation With a Novel Heterozygous KRIT1 Variation

被引:5
作者
Cheng, Dan [1 ]
Shang, Xiang [2 ]
Gao, Wanli [2 ]
Barkhof, Frederik [3 ,4 ]
Liu, Yaou [1 ]
机构
[1] Capital Med Univ, Dept Radiol, Beijing Tiantan Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Dept Obstet, Beijing Tiantan Hosp, Beijing, Peoples R China
[3] UCL Inst Neurol & Healthcare Engn, London, England
[4] Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
关键词
D O I
10.1212/WNL.0000000000012852
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objectives To identify fetal familial cerebral cavernous malformation (CCM) and a novel variation. Methods A 37-year-old pregnant woman (G4P0) presented with right-handed numbness since 2 weeks at 31 weeks of gestation. Evaluation with brain MRI revealed multiple CCMs. As a result, fetal MRI, fetal whole exome sequencing, and maternal Sanger sequencing were performed. Results The mother's brain MRI demonstrated numerous CCMs involving the brain stem, cerebral hemispheres, and cerebellum. Fetal MRI showed a CCM located in the left frontal lobe in susceptibility-weighted imaging (SWI). The neuroimaging characteristics of the mother and the fetus suggested that their CCMs may be familial. Genetic analysis revealed a novel variation in KRIT1 (c.1A>G, p.0?), also called CCM1, in the mother and the baby. The mother delivered a daughter at 32 weeks of gestation with an Apgar score of 10 by cesarean section. Discussion This variation of the initial codon in the KRIT1 gene leads to a phenotype with an early-onset. To our knowledge, this is the first-ever reported case of fetal familial CCM and this novel variation. Brain MRI has excellent sensitivity and specificity, providing the best option for detecting CCMs, even in utero, primarily when SWI is used.
引用
收藏
页码:986 / 988
页数:3
相关论文
共 7 条
[1]   Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel [J].
Akers, Amy ;
Salman, Rustam Al-Shahi ;
Awad, Issam A. ;
Dahlem, Kristen ;
Flemming, Kelly ;
Hart, Blaine ;
Kim, Helen ;
Jusue-Torres, Ignacio ;
Kondziolka, Douglas ;
Lee, Cornelia ;
Morrison, Leslie ;
Rigamonti, Daniele ;
Rebeiz, Tania ;
Tournier-Lasserve, Elisabeth ;
Waggoner, Darrel ;
Whitehead, Kevin .
NEUROSURGERY, 2017, 80 (05) :665-679
[2]   Natural history and imaging prevalence of cavernous malformations in children and young adults Clinical article [J].
Al-Holou, Wajd N. ;
O'Lynnger, Thomas M. ;
Pandey, Aditya S. ;
Gemmete, Joseph J. ;
Thompson, B. Gregory ;
Muraszko, Karin M. ;
Garton, Hugh J. L. ;
Maher, Cormac O. .
JOURNAL OF NEUROSURGERY-PEDIATRICS, 2012, 9 (02) :198-205
[3]   Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease A Review [J].
Chohan, Muhammad O. ;
Marchio, Serena ;
Morrison, Leslie A. ;
Sidman, Richard L. ;
Cavenee, Webster K. ;
Dejana, Elisabetta ;
Yonas, Howard ;
Pasqualini, Renata ;
Arap, Wadih .
JAMA NEUROLOGY, 2019, 76 (04) :492-500
[4]   Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial [J].
Mabray, Marc C. ;
Caprihan, Arvind ;
Nelson, Jeffrey ;
McCulloch, Charles E. ;
Zafar, Atif ;
Kim, Helen ;
Hart, Blaine L. ;
Morrison, Leslie .
TRANSLATIONAL STROKE RESEARCH, 2020, 11 (03) :319-321
[5]   Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma [J].
Polster, Sean P. ;
Sharma, Anukriti ;
Tanes, Ceylan ;
Tang, Alan T. ;
Mericko, Patricia ;
Cao, Ying ;
Carrion-Penagos, Julian ;
Girard, Romuald ;
Koskimaki, Janne ;
Zhang, Dongdong ;
Stadnik, Agnieszka ;
Romanos, Sharbel G. ;
Lyne, Sean B. ;
Shenkar, Robert ;
Yan, Kimberly ;
Lee, Cornelia ;
Akers, Amy ;
Morrison, Leslie ;
Robinson, Myranda ;
Zafar, Atif ;
Bittinger, Kyle ;
Kim, Helen ;
Gilbert, Jack A. ;
Kahn, Mark L. ;
Shen, Le ;
Awad, Issam A. .
NATURE COMMUNICATIONS, 2020, 11 (01)
[6]   RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations [J].
Shenkar, Robert ;
Shi, Changbin ;
Austin, Cecilia ;
Moore, Thomas ;
Lightle, Rhonda ;
Cao, Ying ;
Zhang, Lingjiao ;
Wu, Meijing ;
Zeineddine, Hussein A. ;
Girard, Romuald ;
McDonald, David A. ;
Rorrer, Autumn ;
Gallione, Carol ;
Pytel, Peter ;
Liao, James K. ;
Marchuk, Douglas A. ;
Awad, Issam A. .
STROKE, 2017, 48 (01) :187-+
[7]   Familial Cerebral Cavernous Malformations [J].
Zafar, Atif ;
Quadri, Syed A. ;
Farooqui, Mudassir ;
Ikram, Asad ;
Robinson, Myranda ;
Hart, Blaine L. ;
Mabray, Marc C. ;
Vigil, Catherine ;
Tang, Alan T. ;
Kahn, Mark L. ;
Yonas, Howard ;
Lawton, Michael T. ;
Kim, Helen ;
Morrison, Leslie .
STROKE, 2019, 50 (05) :1294-1301